October is Breast Cancer Awareness Month, and CURE is here to address some of the most common questions patients have after a ...

The FDA has approved Zepzelca with Tecentriq or Tecentriq Hybreza for extensive-stage small cell lung cancer.

Emotional support is just as important. Working with counselors, gynecologists and oncologists, pelvic physical therapy helps ...

The experience of cancer and the COVID-19 pandemic highlighted the importance of gratitude and living a life worthy of a ...

As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...

The U.S. Food and Drug Administration (FDA) has approved its Guardant360® CDx as a companion diagnostic to identify patients ...

Twice-daily radiation showed better survival and quality of life compared to once-daily radiation, easing concerns about its ...

Surgery, specifically an esophagectomy (removal of part or all of the esophagus and surrounding lymph nodes), is a common ...

In September 2025, the U.S. Food and Drug Administration (FDA) approved several new cancer therapies and supportive care ...

As October marks Breast Cancer Awareness Month, CURE sat down for a candid conversation with breast cancer survivor and ...

Enoby and Xtrenbo are FDA-approved biosimilars for denosumab, providing cost-effective alternatives to Prolia and Xgeva for ...

Lynch syndrome affects 1 in 279 Americans, increasing cancer risk and highlighting the need for genetic testing and ...